Some people may find that Wegovy suits them better if they experience persistent nausea, digestive discomfort, or other side effects while using Mounjaro
Always prioritize open communication with your healthcare team to ensure a comprehensive and safe approach to integrating supplements with GLP-1 therapy
The Bigger Picture With superior half-life, bioavailability, and potency , ASC35 positions Ascletis at the forefront of next-generation incretin therapeutics , aiming to challenge weekly GLP-1s like tirzepatide with a monthly, longer-acting alternative
Patients should inform their procedural and anesthesia teams if they take GLP-1 or dual incretin therapy, including Ozempic, Wegovy, Rybelsus, Trulicity, Victoza, Saxenda, Mounjaro, or Zepbound